Evidence map›Paper›PMID 40428065›Full record

ArticleBioengineering (Basel, Switzerland)2025

Bilayer Type I Atelocollagen Scaffolds for In Vivo Regeneration of Articular Cartilage Defects.

Sang Hun Woo, Bo Keun Lee, Andrew S Kwak, Jin Hyo Yang, Seo Yeon Kim, Man Soo Kim, Ji Chul Yoo

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sang Hun WooResearch & Development Headquarters, Cellontech Co., Ltd., Seoul 04783, Republic of Korea.ORCID 0000-0002-3300-1072
Bo Keun LeeResearch & Development Headquarters, Cellontech Co., Ltd., Seoul 04783, Republic of Korea.ORCID 0009-0007-5287-7495
Andrew S KwakResearch & Development Headquarters, Cellontech Co., Ltd., Seoul 04783, Republic of Korea.
Jin Hyo YangResearch & Development Headquarters, Cellontech Co., Ltd., Seoul 04783, Republic of Korea.
Seo Yeon KimResearch & Development Headquarters, Cellontech Co., Ltd., Seoul 04783, Republic of Korea.
Man Soo KimDepartment of Orthopaedic Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University, Seoul 06591, Republic of Korea.ORCID 0000-0002-1374-9964
Ji Chul YooResearch & Development Headquarters, Cellontech Co., Ltd., Seoul 04783, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Articular cartilage has limited regenerative potential due to its anatomical characteristics, making complete recovery from damage challenging. Microfracture (MFx) is a widely used technique to promote cartilage healing, often enhanced with scaffolds to improve outcomes. In this study, we compared the efficacy of bilayer atelocollagen and standard collagen scaffolds combined with MFx in treating osteochondral defects in a rabbit model. Three articular cartilage defects were created in the femoral condyle of each rabbit and treated with either MFx plus a bilayer atelocollagen scaffold (test group), MFx plus a standard collagen scaffold (positive group), or MFx alone (negative group). Macroscopic and histological assessments were performed at 3, 6, and 12 weeks. By week 12, macroscopic examination showed hyaline-like cartilage restoration in the test group, while the positive group exhibited restoration with some overgrowth, and the negative group showed no restoration. Histological analysis revealed significantly better restoration in the test group than in the negative group, with comparable outcomes between the test and positive groups. These findings suggest that bilayer atelocollagen scaffold implantation following MFx is a promising treatment for articular cartilage defects and may provide a viable therapeutic option for patients with cartilage damage.

Indexed as

articular cartilagecollagenextracellular matrixmicrofractureregeneration

Identifiers

PMID40428065
PMCPMC12109255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.